Enzo is a pioneer in labeling and detection technologies, leading the convergence of clinical laboratories, life sciences, and therapeutics through the development of unique platforms. Enzo is committed to providing cost effective products and services, while maintaining its standard of high performance and easily adaptable solutions for molecular diagnostics. For the quantitative detection of nucleic acid in samples, Enzo introduces the AMPIPROBE® platform. The AMPIPROBE® technology incorporates probe detection in primer design, employing a combination of fluorescent reporter-labeled primers and quencher-labeled primers. DNA is amplified in a process akin to traditional PCR. To learn more about Enzo’s AMPIPROBE® technology, please visit enzolifesciences.com/AMPIPROBE
New research suggests that the cells’ protein factories have preferences for specific messenger RNAs they translate.